News

Declaration on the Effectiveness of Bioperfectus SARS-CoV-2 Antigen Rapid Test Kit against New Variant Omicron

News
2021-12-02

The spread of the new variant “Omicron” is faster than expected. The countries and regions with reported Omicron cases on the GISAID website have been increased to twenty-one on Dec. 2, 2021. The data only showed the number of submitted sequenced cases, which might be just the tip of the iceberg.

Source: https://www.gisaid.org/hcov19-variants/

Facing this more contagious variant, not only our real-time PCR kits but also our antigen rapid test kit stay reliable and effective. After an in-silico analysis and simulation experiment with recombinant proteins, although the Omicron has mutation sites on the Nucleocapsid Protein of SARS-CoV-2, there is no influence on the detection region of Bioperfectus Novel Corona Virus (SARS-CoV-2) Ag Rapid Test Kit. Therefore, our kit effectively shows no drop-off in sensitivity and specificity in face of the Omicron variant.